Clinical Trials Logo

Clinical Trial Summary

Annual trial for registration influenza vaccine with the strain composition for season 2009/2010.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00918268
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date June 2009
Completion date July 2009

See also
  Status Clinical Trial Phase
Terminated NCT00359554 - Influenza Vaccination of Nursing Home Workers. N/A
Completed NCT00519064 - Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases Phase 3
Completed NCT00522067 - Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases. Phase 2
Completed NCT00316615 - Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects. Phase 2
Completed NCT01346592 - Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age Phase 3